147031-26-3

Upstream product

• 147031-24-1 5,6,10,11-tetrahydro-8-methyl-benzo[g]pyrazino[1,2-a]indol-3-ol 
• 147031-09-2 N-[2-[4,5-dihydro-7-hydroxy-1H-benzo[g]indol-1-yl)ethyl]acetamide 
• 147031-08-1 N-[2-(4,5-dihydro-7-methoxy-1H-benz[g]indol-1-yl)ethyl]-acetamide 
• 147581-49-5 trifluoromethanesulfonic acid 5,6,10,11-tetrahydro-8-methylbenzopyrazino<1,2-a>indol-3-yl ester 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 147031-10-5 carbonic acid 1-(2-N-acetylamino-ethyl)-4,5-dihydro-1H-benzo[g]indol-7-yl ester 4-nitrobenzyl ester 
• 147581-67-7 Carbonic acid 8-methyl-5,6,10,11-tetrahydro-9,11a-diaza-benzo[c]fluoren-3-yl ester 4-nitro-benzyl ester 
• 147031-07-0 2-((E)-But-2-enyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one 
• 147581-70-2 2-(6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetaldehyde 

Relevant academic research and scientific papers

Design and Synthesis of Novel and Potent Monoamine Oxidase Inhibitors

Reversible and selective monoamine oxidase-A inhibitors (RIMA's) like moclobemide (Aurorix) have rehabilitated the use of MAO inhibitors as drugs of choice in depression.Starting from the structure of moclobemide, we tried to identify novel